Consistent with the effect of LEF1 OP‐V1 on tumor growth, LEF1 OP‐V1 treatment decreased LEF1 protein and inhibited LEF1/β‐catenin target gene expression in tumors (Figure 4I,J). This evidence concerns the gene LEF1 and neoplasm.